Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482664
Status:
COMPLETED
Last Update Posted:
2010-11-01
First Post:
2007-06-01
Brief Title:
The Efficacy Safety And Toleration Of CP-866087 In Pre-Menopausal Women With Female Sexual Arousal Disorder
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 2a Multi-Centre Double Blind Placebo Controlled Cross-Over Trial To Investigate The Efficacy Safety And Toleration Of CP-866087 In Pre-Menopausal Women Diagnosed With Female Sexual Arousal Disorder FSAD
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
CP-866087 is a non-hormonal compound acting on the central nervous system which has been shown in animal models to restore sexual function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None